| molecular function |
|---|
| | GO:0017124 | | SH3 domain binding | | Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins. |
| | GO:0016787 | | hydrolase activity | | Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3. |
| | GO:0019900 | | kinase binding | | Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group. |
| | GO:0016791 | | phosphatase activity | | Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate. |
| | GO:0004721 | | phosphoprotein phosphatase activity | | Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0004725 | | protein tyrosine phosphatase activity | | Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate. |
| | GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
| biological process |
|---|
| | GO:0030217 | | T cell differentiation | | The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex. |
| | GO:0006914 | | autophagy | | The process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation. |
| | GO:0071225 | | cellular response to muramyl dipeptide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan. |
| | GO:0016311 | | dephosphorylation | | The process of removing one or more phosphoric (ester or anhydride) residues from a molecule. |
| | GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| | GO:0031663 | | lipopolysaccharide-mediated signaling pathway | | A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system. |
| | GO:0043508 | | negative regulation of JUN kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of JUN kinase activity. |
| | GO:0050868 | | negative regulation of T cell activation | | Any process that stops, prevents, or reduces the frequency, rate or extent of T cell activation. |
| | GO:0050860 | | negative regulation of T cell receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. |
| | GO:0010507 | | negative regulation of autophagy | | Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
| | GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:1900165 | | negative regulation of interleukin-6 secretion | | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-6 secretion. |
| | GO:2000483 | | negative regulation of interleukin-8 secretion | | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-8 secretion. |
| | GO:0070433 | | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 2 (NOD2) pathway. |
| | GO:1903753 | | negative regulation of p38MAPK cascade | | Any process that stops, prevents or reduces the frequency, rate or extent of p38MAPK cascade. |
| | GO:0032720 | | negative regulation of tumor necrosis factor production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production. |
| | GO:0035335 | | peptidyl-tyrosine dephosphorylation | | The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine. |
| | GO:0035644 | | phosphoanandamide dephosphorylation | | The process of removing one or more phosphate groups from a phosphorylated anandamide. |
| | GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| | GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:1902715 | | positive regulation of interferon-gamma secretion | | Any process that activates or increases the frequency, rate or extent of interferon-gamma secretion. |
| | GO:1902523 | | positive regulation of protein K63-linked ubiquitination | | Any process that activates or increases the frequency, rate or extent of protein K63-linked ubiquitination. |
| | GO:0034141 | | positive regulation of toll-like receptor 3 signaling pathway | | Any process that activates or increases the frequency, rate, or extent of toll-like receptor 3 signaling pathway. |
| | GO:0034145 | | positive regulation of toll-like receptor 4 signaling pathway | | Any process that activates or increases the frequency, rate, or extent of toll-like receptor 4 signaling pathway. |
| | GO:0032481 | | positive regulation of type I interferon production | | Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
| | GO:0006470 | | protein dephosphorylation | | The process of removing one or more phosphoric residues from a protein. |
| | GO:0050855 | | regulation of B cell receptor signaling pathway | | Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell. |
| | GO:1901222 | | regulation of NIK/NF-kappaB signaling | | Any process that modulates the frequency, rate or extent of NIK/NF-kappaB signaling. |
| | GO:0050856 | | regulation of T cell receptor signaling pathway | | Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. |
| | GO:0045088 | | regulation of innate immune response | | Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection. |
| | GO:0032817 | | regulation of natural killer cell proliferation | | Any process that modulates the frequency, rate or extent of natural killer cell proliferation. |
| | GO:0032496 | | response to lipopolysaccharide | | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| cellular component |
|---|
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0009898 | | cytoplasmic side of plasma membrane | | The leaflet the plasma membrane that faces the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
Description
